Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies - PubMed (original) (raw)
Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies
M Zhang et al. J Mol Cell Cardiol. 2001 May.
Abstract
M. Zhang, D. Methot, V. Poppa, Y. Fujio, K. Walsh and C. E. Murry. Cardiomyocyte Grafting for Cardiac Repair: Graft Cell Death and Anti-Death Strategies. Journal of Molecular and Cellular Cardiology (2001) 33, 907-921. Recent studies indicate that cardiomyocyte grafting forms new myocardium in injured hearts. It is unknown, however, whether physiologically significant amounts of new myocardium can be generated. Pilot experiments showed that death of grafted rat neonatal cardiomyocytes limited formation of new myocardium after acute cryoinjury. Time-course studies showed that, at 30 min after grafting, only 1.8(+/-0.4)% of graft cells were TUNEL-positive. At 1 day, however, TUNEL indices increased to 32.1(+/-3.5)% and remained high at 4 days, averaging 9.8(+/-3.8)%. By 7 days, TUNEL decreased to 1.0(+/-0.2)%. Electron microscopy revealed that dead cells had features of both irreversible ischemic injury and apoptosis. To test whether ischemia contributed to poor graft survival, grafts were placed into vascularized 2-week-old cardiac granulation tissue or normal myocardium. TUNEL indices were reduced by 53% and 86%, respectively. Adenoviral infection of graft cells with the cytoprotective kinase Akt, or constitutively active Akt, reduced TUNEL indices by 31% and 40%, respectively, compared to beta -gal-transfected controls. Neither treatment reached statistical significance compared to untreated controls, however. Heat shock reduced cardiomyocyte death in vitro in response to serum deprivation, glucose depletion, and viral activation of the Fas death pathway. When cardiomyocytes were heat shocked prior to grafting, graft cell death in vivo was reduced by 54% at day 1. Therefore, high levels of cardiomyocyte death occur for at least 4 days after grafting into injured hearts, in large part due to ischemia. Death can be limited by activating the Akt pathway and even more effectively by heat shock prior to transplantation.
Copyright 2001 Academic Press.
Similar articles
- Akt activation protects rat liver from ischemia/reperfusion injury.
Harada N, Hatano E, Koizumi N, Nitta T, Yoshida M, Yamamoto N, Brenner DA, Yamaoka Y. Harada N, et al. J Surg Res. 2004 Oct;121(2):159-70. doi: 10.1016/j.jss.2004.04.016. J Surg Res. 2004. PMID: 15501455 - Bax and apoptosis in acute and chronic rejection of rat cardiac allografts.
Dong C, Granville DJ, Tuffnel CE, Kenyon J, English D, Wilson JE, McManus BM. Dong C, et al. Lab Invest. 1999 Dec;79(12):1643-53. Lab Invest. 1999. PMID: 10616213 - Strategic advantages of insulin-like growth factor-I expression for cardioprotection.
Chao W, Matsui T, Novikov MS, Tao J, Li L, Liu H, Ahn Y, Rosenzweig A. Chao W, et al. J Gene Med. 2003 Apr;5(4):277-86. doi: 10.1002/jgm.347. J Gene Med. 2003. PMID: 12692862 - [Ischemic heart disease and apoptosis].
Takemura G, Ohno M, Fujiwara H. Takemura G, et al. Rinsho Byori. 1997 Jul;45(7):606-13. Rinsho Byori. 1997. PMID: 9256005 Review. Japanese. - Myocardial aging and senescence: where have the stem cells gone?
Sussman MA, Anversa P. Sussman MA, et al. Annu Rev Physiol. 2004;66:29-48. doi: 10.1146/annurev.physiol.66.032102.140723. Annu Rev Physiol. 2004. PMID: 14977395 Review.
Cited by
- Cell therapy for cardiovascular regeneration.
Takehara N. Takehara N. Ann Vasc Dis. 2013;6(2):137-44. doi: 10.3400/avd.ra.13.00019. Epub 2013 Apr 20. Ann Vasc Dis. 2013. PMID: 23825492 Free PMC article. - In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments : In vitro augmentation of mesenchymal stem cells viability.
Amiri F, Jahanian-Najafabadi A, Roudkenar MH. Amiri F, et al. Cell Stress Chaperones. 2015 Mar;20(2):237-51. doi: 10.1007/s12192-014-0560-1. Epub 2014 Dec 20. Cell Stress Chaperones. 2015. PMID: 25527070 Free PMC article. Review. - Tissue Engineering Strategies for Myocardial Regeneration: Acellular Versus Cellular Scaffolds?
Domenech M, Polo-Corrales L, Ramirez-Vick JE, Freytes DO. Domenech M, et al. Tissue Eng Part B Rev. 2016 Dec;22(6):438-458. doi: 10.1089/ten.TEB.2015.0523. Epub 2016 Jul 21. Tissue Eng Part B Rev. 2016. PMID: 27269388 Free PMC article. Review. - Opportunities and challenges: stem cell-based therapy for the treatment of ischemic stroke.
Tang YH, Ma YY, Zhang ZJ, Wang YT, Yang GY. Tang YH, et al. CNS Neurosci Ther. 2015 Apr;21(4):337-47. doi: 10.1111/cns.12386. Epub 2015 Feb 10. CNS Neurosci Ther. 2015. PMID: 25676164 Free PMC article. Review. - Advances in Synthesis and Applications of Self-Healing Hydrogels.
Fan L, Ge X, Qian Y, Wei M, Zhang Z, Yuan WE, Ouyang Y. Fan L, et al. Front Bioeng Biotechnol. 2020 Jul 21;8:654. doi: 10.3389/fbioe.2020.00654. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32793562 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous